ResearcherUtrecht UniversityActive in the last 2 years
Anouk E.J. Latenstein
Matched on ORCID iD 0000-0003-3492-4968; OpenAlex author ID A5063019098. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 4, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2020: 6 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 7
- Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial. First author DOI 10.1001/jamasurg.2023.7872↗
- Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejca.2019.11.002↗
- Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. First author DOI 10.1016/j.pan.2020.10.032↗
- Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis. Co-author DOI 10.1080/0284186x.2020.1725241↗
- Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making progra… First author DOI 10.1177/2050640620945534↗
- Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled t… Co-author DOI 10.1186/s13063-020-4180-z↗
- Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. First author DOI 10.1245/s10434-020-08235-w↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Izaak Quintus Molenaar · 5 shared papers, 2020 · strength 0.46
- Paper Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population… DOI 10.1080/0284186x.2020.1725241↗
- Paper Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic … DOI 10.1177/2050640620945534↗
- Paper Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2019.11.002↗
- Marc G. Besselink · 5 shared papers, 2020 · strength 0.46
- Paper Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population… DOI 10.1080/0284186x.2020.1725241↗
- Paper Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic … DOI 10.1177/2050640620945534↗
- Paper Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2019.11.002↗
- Johanna W. Wilmink · 4 shared papers, 2020 · strength 0.36
- Paper Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population… DOI 10.1080/0284186x.2020.1725241↗
- Paper Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2019.11.002↗
- Paper Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. DOI 10.1016/j.pan.2020.10.032↗
- Hanneke W.M. van Laarhoven · 4 shared papers, 2020 · strength 0.36
- Paper Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population… DOI 10.1080/0284186x.2020.1725241↗
- Paper Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2019.11.002↗
- Paper Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. DOI 10.1016/j.pan.2020.10.032↗
- Lydia G. van der Geest · 4 shared papers, 2020 · strength 0.36
- Paper Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population… DOI 10.1080/0284186x.2020.1725241↗
- Paper Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2019.11.002↗
- Paper Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. DOI 10.1016/j.pan.2020.10.032↗
- Bas Groot Koerkamp · 4 shared papers, 2020 · strength 0.36
- Paper Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic … DOI 10.1177/2050640620945534↗
- Paper Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2019.11.002↗
- Paper Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. DOI 10.1016/j.pan.2020.10.032↗
- Bert A. Bonsing · 4 shared papers, 2020 · strength 0.36
- Paper Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic … DOI 10.1177/2050640620945534↗
- Paper Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2019.11.002↗
- Paper Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. DOI 10.1016/j.pan.2020.10.032↗
- Casper H.J. van Eijck · 4 shared papers, 2020 · strength 0.36
- Paper Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population… DOI 10.1080/0284186x.2020.1725241↗
- Paper Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2019.11.002↗
- Paper Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. DOI 10.1016/j.pan.2020.10.032↗
- Judith de Vos‐Geelen · 3 shared papers, 2020 · strength 0.27
- Paper Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population… DOI 10.1080/0284186x.2020.1725241↗
- Paper Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2019.11.002↗
- Paper Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. DOI 10.1016/j.pan.2020.10.032↗
- Marjolein Y.V. Homs · 3 shared papers, 2020 · strength 0.27
- Paper Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population… DOI 10.1080/0284186x.2020.1725241↗
- Paper Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. DOI 10.1016/j.pan.2020.10.032↗
- Paper Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. DOI 10.1245/s10434-020-08235-w↗
- Ignace H. J. T. de Hingh · 3 shared papers, 2020 · strength 0.27
- Paper Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2019.11.002↗
- Paper Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. DOI 10.1016/j.pan.2020.10.032↗
- Paper Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. DOI 10.1245/s10434-020-08235-w↗
- Tara M. Mackay · 2 shared papers, 2020 · strength 0.19
- Paper Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population… DOI 10.1080/0284186x.2020.1725241↗
- Paper Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. DOI 10.1016/j.pan.2020.10.032↗
- Jeanin Elise van Hooft · 2 shared papers, 2020 · strength 0.19
- Nadia Haj Mohammad · 2 shared papers, 2020 · strength 0.19
- Marco J. Bruno · 2 shared papers, 2020 · strength 0.19
- Hjalmar C. van Santvoort · 2 shared papers, 2020 · strength 0.18
- Martijn W.J. Stommel · 2 shared papers, 2020 · strength 0.18
- Lianne Scholten · 1 shared paper, 2020 · strength 0.10
- Geert‐Jan Creemers · 1 shared paper, 2020 · strength 0.10
- Pauline A. J. Vissers · 1 shared paper, 2020 · strength 0.09
- Geertjan van Tienhoven · 1 shared paper, 2020 · strength 0.09
- Stijn R. van Roessel · 1 shared paper, 2020 · strength 0.09
- V.E.P.P. Lemmens · 1 shared paper, 2020 · strength 0.09
- Joost M. Klaase · 1 shared paper, 2020 · strength 0.09
- Vincent Erwin de Meijer · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.